Adiponectin is adipocyte-secreted cytokine with potent insulin-sensitizing action in peripheral tissues. The heritability of plasma adiponectin is high in Han Chinese population.
Introduction
Adiponectin is an adipocyte-secreted protein with potent insulinsensitizing action in peripheral tissues such as skeletal muscle and liver. Plasma adiponectin levels are negatively associated with plasma triglycerides, measures of obesity, insulin resistance, and risk of type 2 diabetes but are positively associated with plasma high-density lipoprotein cholesterol (HDL-C) levels. [1] [2] [3] The heritability of plasma adiponectin level is high (30-70%) in European population. [4, 5] A large-scale multiethnic meta-analysis of genome-wide association analysis (GWAS) involving 45,891 individuals identified variants in the LYPLAL1, GNL3, TSC22D2, ADIPOQ, VEGFA, TRIB1, PDE3A, GPR109A, DNAH10, CMIP, CDH13, ZNF664, and PEPD genes associated with plasma adiponectin. [6] A GWAS of participants in the Nurses' Health Study confirmed the association of ADIPOQ variants and found a new locus in the FER gene associated with plasma adiponectin. [7] Another meta-analysis of GWAS involving 14,733 Europeans also confirmed the association of ADIPOQ variants and revealed a novel locus in the ARL15 gene associated with plasma adiponectin. [9] Another GWAS in Filipino women identified a novel signal near KNG1 gene. [8] A recent meta-analysis of GWAS in 7827 East Asians confirmed the association of variants at CDH13, ADIPOQ, PEPD, CMIP, ZNF664, and GPR109A genes and further identified a novel variant at WDR11-FGFR2 gene associated with plasma adiponectin. [9] These variants are also associated with triglycerides, HDL-C, blood pressure, measures of obesity, type 2 diabetes, and cardiometabolic outcomes. [6, 7, 10, 11] Editor: Xiaolin Zhu. This study was supported by the grants (NSC95-3112-B-002-002, NSC96-3112-B-002-002, NSC100-2321-B-002-040) from National Science Council, Executive Yuan, Taiwan.
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We have previously demonstrated a high heritability (h 2 = 0.64) of plasma adiponectin in Chinese population. [12] However, no genetic association study for plasma adiponectin has been carried out in Han Chinese population. In a previous genomewide linkage analysis for plasma adiponectin levels using 376 microsatellite markers in the Stanford Asia-Pacific Program for Hypertension and Insulin Resistance (SAPPHIRe) Chinese family cohort, [12] we identified a single peak with logarithm of odds (LOD) of 3.19 at 39 cM of chromosome 15. In this study, we sought to refine this linkage signal using additional microsatellite markers and performed regional association fine mapping using 68 single-nucleotide polymorphism (SNP) markers. We identified genetic variants in the ryanodine receptor 3 (RYR3) gene associated with plasma adiponectin in Han Chinese.
Methods

The SAPPHIRe study cohort
The SAPPHIRe was a collaborative study that was part of the Family Blood Pressure Program of the National Heart, Lung, and Blood Institute of the National Institutes of Health originally designed to investigate the genetic determinants of hypertension and insulin resistance in Chinese individuals. The study collected sibling pairs who were either concordant or discordant for high blood pressure. Detailed descriptions of the study cohort were published in our previous work. [12, 13] Hypertension was defined as systolic blood pressure ≧140 mm Hg, diastolic blood pressure ≧90 mm Hg, or use of medications for high blood pressure. Individuals with pre-existing chronic illness such as diabetes, cancer, or diseases of the heart, liver, or kidney were excluded. A total of 1153 subjects of Han Chinese descent from 392 families were enrolled at baseline. The institutional review board of TriService General Hospital in Taiwan, the National Taiwan University Hospital (NTUH) Research Ethics Committee, the institutional review board of Taipei Veterans General Hospital, and the institutional review board of Taichung Veterans General Hospital approved this study. Written informed consent was obtained from each participant. The baseline characteristics of participants are summarized in Table 1 .
Selection of tag SNPs and genotyping
Within the linkage region, we selected 68 SNPs in 12 genes including cholinergic receptor, nicotinic, alpha 7 (CHRNA7, (Table 2) . [14] The average physical interval is 17.1 kb. The average call rate is 95.48%. The concordance rate of this system based on 160 genotyping duplications was 99.38%.
Subjects for measurement of gene expression in adipose tissue
We recruited 44 adult subjects undergoing bariatric surgery or elective abdominal surgery such as cholecystectomy or partial hepatectomy in Ming-Sheng General Hospital and Yunlin branch of NTUH in Taiwan. Abdominal omental adipose tissues were sampled in a fasting state during surgery and were placed in liquid nitrogen immediately until processing. The study was approved by the institutional review board of Ming-Sheng General Hospital and National Taiwan University Hospital. Written informed consent was obtained from each patient. Their baseline characteristics are summarized in Table 1 .
Reverse transcription and quantitative real-time PCR
Total RNA was isolated using REzol C&T reagent (Protech, Taipei, Taiwan) and reverse transcribed with SuperScript III (Invitrogen, Carlsbad, CA) according to the manufacturer's instructions. Polymerase chain reaction amplification was performed using LightCycler FastStart DNA Master Plus SYBR (Roche, Mannheim, Germany). Each sample was analyzed in duplicate and calibrated to the cyclophilin A housekeeping gene. The primer used for RYR3 was PPH20011A (BD Bioscience, New Jersey, USA). The primers used for PPLA (cyclophilin A) were forward (50-GCATACGGGTCCTGGCATCTTGTCC-30) and reverse (50-ATGGTGATCTTCTTGCTGGTCTTGC-30).
Statistical analysis
The genome-wide scans were performed for logarithm-transformed adiponectin with adjustments for age and gender. Variance component model was used for linkage analysis using the Sequential Oligogenic Linkage Analysis Routines computer package. [15] The detailed description of linkage analysis was published in our previous work. [12, 13] Likelihood ratio tests were used to test for the null hypothesis of no linkage. LOD scores were calculated as logarithm to base 10 of the likelihood ratios. A LOD score exceeding 3.3 was considered to be of genome-wide significance for evidence of linkage, whereas a LOD score >1.9 was suggestive of evidence for linkage. One-unit LOD support intervals were obtained by identifying the peak for the maximum LOD score on the plot of the linkage results, dropping down 1 LOD unit and finding the chromosomal region defined by the shoulders of the curve. For regional fine mapping, we used family-based association tests for single-SNP and haplotype Data are presented as mean ± standard deviation. BMI = body mass index, DBP = diastolic blood pressure, SAPPHIRe = Stanford Asia-Pacific Program for Hypertension and Insulin Resistance, SBP = systolic blood pressure.
Chang et al. 95:44 Medicine association analysis. [16] Hardy-Weinberg equilibrium test was performed before marker-trait analysis.
Results
Fine mapping of genome-wide linkage signal identified RYR3 as QTL for plasma adiponectin
In a previous genome-wide linkage scan in the SAPPHIRe Chinese family cohort, we identified a linkage signal on chromosome 15 at 39 cM (LOD score = 3.19 with 1-LOD support interval at 31-48 cM) with plasma adiponectin levels using microsatellite marker spanned at an interval of approximately 17 cM. To refine this signal, we placed additional 6 microsatellite markers and mapped a quantitative trail locus (QTL) located at 31 cM (LOD = 3.04 with 1-LOD support interval at 24-34 cM) (Fig. 1) . Compared to original linkage signal, the additional markers resulted in a peak shifted by about 8 cM and the 1-LOD support interval shortened by 7 cM. Within this region, we further genotyped a total of 68 SNPs for the 12 genes including the CHRNA7, ARHGAP11A, SCG5, GREM1, RYR3, CHRM5, SLC12A6, NUT, AYTL3, GOLGA8A, AQR, and RASGRP1 genes.
Sliding window analysis using family-based association test found that haplotypes of the RYR3 gene had strongest association with plasma adiponectin levels (P = 0.001) (Fig. 2) . RYR3 haplotypes were also associated with systolic (P = 0.001) and diastolic (P = 7.1 Â 10 À4 ) blood pressure and HDL-C (P = 1.4 Â 10 À4 ) (Fig. 3) .
Correlation between RYR3 and adiponectin expression in human adipose tissue
Since adiponectin is expressed in adipose tissues, we examined the correlation between expression of RYR3 and adiponectin in 44 human adipose tissues. We found an inverse relationship between RYR3 and adiponectin expression in omental (r = À 0.34, P = 0.02) adipose tissues (Fig. 4) , suggesting that RYR3 is a negative regulator of adiponectin; this finding is consistent with a previous report that silencing of RYR3 both in vitro and in vitro elevated plasma insulin and improved insulin sensitivity.
[17]
Discussion
In this study, we refined the genome-wide linkage signal of our previous study using additional microsatellite marker and mapped a QTL located in chromosome 15 at 31 cM with LOD of 3.04. Within this linkage region, we identified variants in the RYR3 gene associated with plasma adiponectin. RYR3 genetic variants were also associated with HDL-C, waist-hip ratio, and blood pressures. In addition, RYR3 expression was inversely associated with adiponectin expression in human abdominal adipose tissues.
Adiponectin is an adipokine with potent insulin-sensitizing and antiatherosclerosis actions. Previous genome-wide association studies (GWAS) or meta-analyses of GWAS in European population have identified ∼10 SNPs associated with plasma adiponectin levels. [6, 7, 10, 11] The SNPs are also associated with Table 2 Single-nucleotide polymorphisms (SNPs) genotyped in genes within linkage region. 
76.6 rs7181389, rs4567661, rs7138104, rs4923799, rs11855910 Figure 1 . Genetic association of RYR3 with circulating adiponectin levels. Genome-wide multipoint linkage analysis of plasma adiponectin levels. Multipoint LOD scores using are depicted by solid lines (blue line indicates previous LOD scores using 12 microsatellite markers; black line indicates LOD scores using additional 6 microsatellite markers). LOD = logarithm of odds, RYR3 = ryanodine receptor 3.
Chang et al. 95:44 www.md-journal.com altered risk of type 2 diabetes, plasma triglycerides, HDL-C, blood pressure, and waist-hip ratio. [6, 7, 10, 11] Here we reported that novel variants in the RYR3 gene are associated with plasma adiponectin levels in Chinese population.
Interestingly, a recent European GWAS also identified a variant in the RYR3 gene (rs6495001) associated with plasma adiponectin in 2097 men. [10] This variant is associated with plasma adiponectin level in both stage 1 (P = 8.8 Â 10
À6
) and Chang et al. 95: 44 Medicine stage 1 + 2 (P = 0.039) analyses. [10] We tried to replicate this finding in our dataset. However, this SNP is not polymorphic in Chinese population (data not shown) and therefore a direct comparison is not possible. However, the appearance of similar signals from 2 independent studies suggests RYR3 as a genetic determinant of plasma adiponectin.
The RYR3 gene encodes for a cation channel that releases intracellular calcium storage pools. Three RyR isoforms were identified with tissue-specific expression pattern including RyR1, RyR2, and RyR3. RyR1 is expressed mainly in skeletal muscle while RyR2 is expressed in heart. RyR3 is ubiquitously expressed. Knockdown of RyR3 in preadipocytes has been shown to upregulate adiponectin promoter activity, enhance adiponectin expression, and cause more adiponectin secretion into the medium through activation of activating transcription factor 3. [18] Activating transcription factor 3 is an inducible transcriptional repressor controlling adiponectin expression. [18, 19] Silencing of RyR3 with small interfering RNA in db/db mice and high-fat diet-induced obese mice also increased serum adiponectin level and improved insulin sensitivity. [17] Consistently, we observed an inverse relationship between RYR3 and adiponectin expression in human adipose tissue. Collectively, these data suggest that RyR3 is a suppressor of adiponectin expression.
Our data have some unique strengths. First, this is the first genome-wide linkage analysis and fine association mapping for plasma adiponectin in Chinese population. Second, the familybased design of this study prevented potential confounding by population stratification, a frequent cause for spurious association in case-control association studies. [9] Third, the metabolic phenotypes of the SAPPHIRe cohort are complete, making a comprehensive testing for metabolic phenotypes feasible. However, there are some limitations of our study. First, the significance level of most single-locus association did not pass the study-wide significance threshold. Based on the linkage method, a LOD score exceeding 3.3 was considered to be of genome-wide significance for evidence of linkage, whereas a LOD score >1.9 was suggestive of evidence for linkage. However, a LOD of 3.04 of our studies can still be considered as a highly suggestive signal almost reaching genome-wide significance. Second, although the association of RYR3 genetic variation with plasma adiponectin was also observed in another European GWAS in men, [10] further replication is still needed to confirm the association. Third, only 68 SNPs were used for association testing in our study across a large chromosomal region. A finer mapping would help to identify variants with best association within this region.
Conclusions
In summary, we demonstrated for the first time that genetic variants in the RYR3 gene are associated with plasma adiponectin in Chinese, which is consistent with the finding of a recent GWAS. [10] A reverse relationship between RYR3 and adiponectin expression in human adipose tissue was also observed. These data, together with previous functional investigations, support a role of RYR3 in the regulation of adiponectin expression.
